| Literature DB >> 31148991 |
Obumneme Anyim1, Christian Okafor2, Ekenechukwu Young2, Ijeoma Obumneme-Anyim3, Chidimma Nwatu2.
Abstract
PURPOSE: To determine the pattern and bacteriological characteristics of diabetic foot ulcers in patients attending a tertiary health care facility.Entities:
Keywords: Diabetes mellitus; Nigeria; antibiotic sensitivity
Mesh:
Substances:
Year: 2019 PMID: 31148991 PMCID: PMC6531968 DOI: 10.4314/ahs.v19i1.37
Source DB: PubMed Journal: Afr Health Sci ISSN: 1680-6905 Impact factor: 0.927
Biochemical, Socio-demographic and anthropometric characteristics of the study population
| Mean (SD) | ||||
| Males | Females | Total | ||
| Characteristics | (n=26) | (n=26) | (n=52) | P value |
| Age (years) | 61.7 (9.7) | 58.1 (11) | 59.9 (10.5) | 0.221 |
| Age at diagnosis of DM (years) | 52.6 (11.5) | 43 (12.1) | 47.8 (12.7) | 0.005 |
| Duration of DM (years) | 9.5 (7.7) | 13.6 (6.3) | 11.5 (7.3) | 0.043 |
| BMI (kg/m2) | 24.2 (4.4) | 28.5 (4.9) | 26.4 (5.1) | 0.005 |
| WC (cm) | 88.8 (11.1) | 96.6 (9.8) | 92.8 (11.1) | 0.019 |
| SBP (mmHg) | 129.8 (12.9) | 146 (25.4) | 137.9 (21.6) | 0.006 |
| DBP (mmHg) | 79.2 (12) | 82.7 (10.5) | 81 (11.3) | 0.268 |
| FPG (mmol/L) | 13.1 (5.9) | 10.2 (6.2) | 11.7 (6.2) | 0.089 |
| HbA1c (%) | 9.7 (2.5) | 8.7 (2.9) | 9.2 (2.7) | 0.192 |
| Traders | 13 (50) | 9 (34.6) | 22 (42.3) | |
| Civil servant | 2 (7.7) | 7 (26.9) | 9 (17.3) | |
| Farmers | 3 (11.5) | 4 (15.4) | 7 (13.5) | |
| Retired civil servants | 3 (11.5) | 3 (11.5) | 6 (11.5) | |
| Artisans | 5 (19.2) | - | 5 (9.6) | 0.386 |
| Unemployed | - | 3 (11.5) | 3 (5.8) | |
| Nil | 1 (3.8) | 2 (7.7) | 3 (5.8) | |
| Primary | 14 (53.8) | 12 (46.2) | 26 (50) | 0.26 |
| Secondary | 7 (26.9) | 3 (11.5) | 10 (19.2) | |
| Tertiary | 4 (15.4) | 9 (34.6) | 13 925) | |
Significant (p < 0.05) differences between males and females
Wagner's distribution of the DFU among the participants
| Wagner's | Description of the ulcer | Frequency | Percent |
| Superficial ulcers | 17 | 32.7 | |
| Deep ulcers | 16 | 30.8 | |
| Ulcer with bone involvement | 12 | 23.1 | |
| Forefoot gangrene | 4 | 7.7 | |
| Whole foot gangrene | 3 | 5.8 | |
| 100.0 | |||
Figure 1Distribution of causes of ulcer among study participants
Types and frequencies of isolated organisms
| Types of isolated organisms | Frequency | Percent |
| 9 | 14.1 | |
| 9 | 14.1 | |
| 8 | 12.5 | |
| 11 | 17.2 | |
| 2 | 3.1 | |
| 10 | 15.6 | |
| 4 | 6.3 | |
| 6 | 9.4 | |
| 4 | 6.3 | |
| 1 | 1.6 | |
| 13 | 17.8 | |
| 21 | 28.8 | |
| 2 | 2.7 | |
| 15 | 20.5 | |
| 7 | 9.6 | |
| 6 | 8.2 | |
| 4 | 5.5 | |
| 1 | 1.4 | |
| 4 | 5.5 | |
Susceptibility pattern of isolated aerobic organisms
| Susceptibility pattern (%) | ||||||||||
| Gram positive | Eryth | Ceft | A/Cx | Cef | Levo | Norf | Gent | Oflo | Clin | Cipr |
| 100 | 100 | 55.6 | 100 | 100 | 100 | 55.6 | 77.8 | 77.8 | 77.8 | |
| 54.5 | 54.5 | 54.5 | 54.5 | 100 | 100 | 54.5 | 27.3 | 54.5 | 72.7 | |
| 100 | - | - | - | 100 | 100 | - | - | - | 100 | |
| 60.0 | 60.0 | 40.0 | ND | 80 | 60.0 | 40.0 | 40.0 | 60.0 | 80.0 | |
| - | 50.0 | - | - | 50 | 50.0 | 50.0 | - | 50.0 | 50.0 | |
| 314.5 | 264.5 | 150.1 | 154.5 | 430 | 410 | 200.1 | 145.1 | 242.3 | 380.5 | |
| 62.9 | 52.9 | 30.0 | 38.6 | 86.0 | 82.0 | 40.0 | 29.0 | 48.5 | 76.1 | |
| Nitro | Ceft | Cipr | Gent | Oflo | A/Cv | Pef | Clar | Chlo | Amp | |
| - | 55.6 | 88.9 | 55.6 | 22.2 | 205.5 | 438.9 | 83.3 | 183.3 | 33.3 | |
| 23.3 | 37.8 | 87.8 | 61.1 | 39.4 | 41.1 | 87.8 | 16.7 | 36.7 | 8.3 | |
(Eryth) Erythromycin, (Ceft) Ceftriaxone (A/Cx) Ampicillin/Cloxacillin, (Cef) Cefixime, (Levo) Levofloxacin, (Norf) Norfloxacin, (Gent) Gentamycin, (Oflo) Ofloxacin, (Clin) Clindamycin, (Cipr) Ciprofloxacin, (Nitro) Nitrofurantoin, (A/Cv) Amoxicillin/Clavulanate, (Pef) Pefloxacin, (Clar) Clarithromycin, (Chlo) Chloramphenicol, (Amp) Ampicillin, (ND) not done
NB: Blank cells = 0%
Susceptibility pattern of isolated anaerobic organisms
| Gram positive | Susceptibility pattern (%) | ||||||||
| A/S | Clin | Imip | Ceft | Ceftiz | Metro | Cefo | Amp | Pen | |
| 76.9 | 84.6 | ND | 76.9 | 53.8 | 100 | 76.9 | 84.6 | 84.6 | |
| 73.3 | 100 | ND | 73.3 | 53.3 | 86.7 | 73.3 | 53.3 | 40.0 | |
| 100 | 100 | ND | 50.0 | 50.0 | 100 | 50.0 | 50.0 | 50.0 | |
| 50.0 | 100 | ND | 50.0 | 50.0 | 100 | 50.0 | 100 | 100 | |
| 100 | 100 | ND | - | 100 | 100 | - | - | - | |
| - | 100 | ND | - | - | 100 | - | - | 100 | |
| 400.2 | 584.6 | 0 | 250.2 | 307.1 | 586.7 | 250.2 | 287.9 | 374.6 | |
| 66.7 | 97.4 | 0.0 | 41.7 | 51.2 | 97.8 | 41.7 | 48.0 | 62.4 | |
| 90.5 | 90.5 | 90.5 | 62.0 | 71.4 | 90.5 | 52.4 | ND | ND | |
| 100 | 100 | 50.0 | - | - | 50.0 | - | - | - | |
| 71.4 | 100 | 100 | 71.4 | 71.4 | 100 | 71.4 | 100 | 71.4 | |
[(A/S) Ampicillin/Sulbactam, (Clin) Clindamycin, (Imip) Imipenem, (Ceft) Ceftriaxone (Ceftiz) Ceftizoxime, (Metro) Metronidazole, (Cefo) Cefoxitin, (Amp) Ampicillin, (Pen) Penicillin, (ND) not done] NB: Blank cells = 0%